Live · 27.3k readers this week

Should you actually take it? Real verdicts on the peptides everyone’s Googling.

Hype, hope, or real? Side-by-side: what the internet is claiming, what the evidence backs up, and whether it’s worth your money.

Educational reference. Not medical advice.

SpecimenBPC-157 reference chain
GEPPPGKPADDAGLV
Formula
C62H98N16O22
Mass
1419.53
Evidence
Animal / preclinical
Residues
15

Reality checks

Hot takes, fact-checked.

Browse all
Approved / Clinical4 minApproved

The Libido Peptide Everyone Calls PT-141 Has Been an FDA Drug Since 2019. The Gap Is the Story.

PT-141 has been FDA-approved since 2019 as Vyleesi — and the 2026 compounding wave that reshaped peptide access did not change that.

Fat Loss + GLP-1s4 minEarly human

CagriSema Has a New FDA Filing and ADA 2026 Data. The Half That Isn't Semaglutide Does the Explaining.

The amylin analog inside Novo Nordisk's next weight-loss drug just showed up in the NEJM at ADA 2026 — and it's not semaglutide.

Fitness + Recovery4 minAnecdotal

TB-500 Made the FDA's July 23 Docket. The Recovery Stack Claims Didn't Make the Evidence List.

TB-500 is on the July 23 FDA compounding docket — and the oral comment window closes in three days with the recovery claims still unproven.

Longevity + Skin4 minEarly human

Semax Got a July FDA Hearing Date. The Nootropic Claims Aren't the Agenda.

The ACTH-fragment peptide from Russia just made the FDA's July 24 compounding docket — and the committee is reviewing a pharmacy-access question, not a cognitive-enhancement claim.

Longevity + Skin4 minAnimal / preclinical

MOTS-c Just Made the FDA's July Docket. The 'Exercise Peptide' Frame Has a Problem.

The mitochondrial peptide trending as exercise-in-a-vial just made the FDA's July 23 agenda — but regulators are asking about obesity and osteoporosis, not athletic optimization.

Fitness + Recovery4 minHuman-supported

Sermorelin Escaped the 2023 Peptide Purge. FDA Attestation Rules in 2026 Found It Anyway.

Sermorelin survived the 2023 compounding crackdown by not being on the restricted list. In 2026, new FDA attestation rules found it anyway.

Browse all 49 reality checks

Search the index

Find the peptide everyone’s talking about. See if it’s real.

109peptides decoded40FDA-approved93with human data
10 Showing top 10 of 109 — search to see more
Browse all 109 peptides in the Atlas
What people are asking right nowSemaglutideShould you actually try semaglutide for weight loss?TirzepatideTirzepatide vs Ozempic — which one actually works?BPC-157Is BPC-157 the recovery hack — or all hype?

How we cut through the noise

The hype, the science, and where they don’t match.

Browse all

01 / PROFILE

Peptide Profiles

Each entry explains what the peptide is, why people search for it, the proposed mechanism, and where the evidence stops.

BPC-157Animal / preclinicalRecovery claims

02 / NEWS

Reality checks, daily

Clickbait headlines with real receipts. Daily article on a trending peptide — what people are claiming, what the evidence actually shows, where the line is.

TRIALSPUBMEDLABELS

03 / SAFETY

Safety Context

Profiles include risks, unknowns, approval context, and clear boundaries around dosing, sourcing, and personal medical advice.

SAFETY NOTEEducational content only; clinical decisions belong with qualified care.

04 / CATEGORY

Category Index

Compare fitness and recovery, GLP-1 and metabolic, longevity and skin, endogenous biology, and approved clinical peptides.

Compact category topologyN01N02N03N04N05N06N07N08PROFILE MAPEVIDENCE LAYERCATEGORY CLUSTER
Evidence scanner

Every claim gets a label before it gets a headline.

PeptideFactCheck separates approved use, human signal, early research, preclinical biology, anecdotes, and unknowns so curiosity does not become fake certainty.

ApprovedOfficial regulatory approval exists for at least one specific use.
Human-supportedHuman clinical data supports at least some claims, with scope and limits made explicit.
Early humanSmall, preliminary, or narrow human studies exist, but the evidence is not mature.
Animal / preclinicalThe strongest evidence is animal, cell, or mechanism research rather than clinical outcomes.
AnecdotalMost public claims come from user reports, clinics, vendors, forums, or social media.
UnknownReliable source data is too sparse or inconsistent to classify confidently.

Why you can trust the verdicts

We don’t take influencers’ word for it. Here’s who we DO trust.

IUPHAR/BPS, PubChem, UniProt, RCSB PDB, PubMed, Europe PMC, and ClinicalTrials.gov are used for molecular and research context.

FDA Orange Book, DailyMed, openFDA, and FDA safety communications are used for U.S. regulatory and label context.

Vendor pages, forum posts, and clinic claims can explain public interest, but they are not treated as authoritative evidence.

SAFETY NOTEThis content is educational only and does not replace medical advice. Peptide use may carry risks and should be discussed with a qualified medical professional.